[Biochemical and experimental aspects of the lipid-lowering drugs pharmacology (author's transl)].
作者信息
Jacotot B
出版信息
Sem Hop. 1979;55(41-42):1947-55.
PMID:231322
Abstract
The analysis of the mode of action of lipid-lowering drugs requires a better understanding of the lipoprotein and cholesterol metabolism processes. The strides observed during the last years in this field are conditioning the development of pharmacologic and therapeutic researches. Moreover the use of new experimental models contributes to this progress by multiplying the study ways.
摘要
相似文献
1
[Biochemical and experimental aspects of the lipid-lowering drugs pharmacology (author's transl)].
Sem Hop. 1979;55(41-42):1947-55.
2
[Biochemical and experimental aspects of the lipid-lowering drugs pharmacology (author's transl)].
Pathol Biol (Paris). 1979 May;27(5):305-13.
3
[Hypolipidaemic agents (author's transl)].
Nouv Presse Med. 1980 Oct 30;9(40):2947-50.
4
[Mechanism of action of drugs affecting lipid metabolism].[影响脂质代谢的药物作用机制]
Minerva Med. 1975 Oct 6;66(66):3458-68.
5
[Toxicological and pharmacological studies on a new drug: pirfibrate (EL-466) (author's transl)].
Arch Farmacol Toxicol. 1980 Dec;6(3):255-64.
6
7
[Experimental models of atherosclerosis. Contribution, limits and trends].[动脉粥样硬化的实验模型。贡献、局限性与趋势]
Arch Mal Coeur Vaiss. 1991 Nov;84(11):1593-603.
8
[Mechanism of action of antilipemic drugs].
Arch Mal Coeur Vaiss. 1992 Sep;85 Spec No 2:109-12.
9
Animal models of atherosclerosis.
Adv Vet Sci Comp Med. 1972;16:151-73.
10
Effects of experimental atherosclerosis on cerebral blood flow in rabbits. Reversal by sorbinicate.
Artery. 1982;11(1):64-73.
Zotero 插件